- 1D
- 3D
- 1W
- 1M
- 6M
- 1Y
- 3Y
- 5Y
Announcements
- Research Note Published
- Clinical Trial & License Agreement Update
- Conversion of CLNs
- Ex-Entitlement Date - Unlisted RNV Shares
- Determination of Record Date and Entitlement
- Holding(s) in Company
- Director/PDMR Shareholding
- Executed License Agreement & Transaction Update
- MK Cell Out-License & Lyramid SPA Update
- Fundraise & Transaction Update
More ▼
Key statistics
On Friday, Roquefort Therapeutics PLC (ROQ:LSE) closed at 1.20, 20.00% above the 52 week low of 1.00 set on Feb 03, 2026.
52-week range
| Open | 1.20 |
|---|---|
| High | 1.20 |
| Low | 1.18 |
| Bid | 1.00 |
| Offer | 1.50 |
| Previous close | 1.20 |
| Average volume | 133.52k |
|---|---|
| Shares outstanding | 163.73m |
| Free float | 97.64m |
| P/E (TTM) | -- |
| Market cap | 1.96m GBP |
| EPS (TTM) | -0.0063 GBP |
Data delayed at least 20 minutes, as of Feb 06 2026 15:58 GMT.
More ▼
